Keiji Shimada
- Molecular Biology top 2%
- Oncology top 2%
- Cancer Research top 2%
- Surgery top 5%
- Immunology top 5%
- Co-authors
- Noboru KonishiMitsutoshi NakamuraEiwa IshidaKiyohide FujimotoSatoshi AnaiTomomi FujiiKazutake TsujikawaMunehiro Kishi
- Topics
- Bladder and Urothelial Cancer Treatments (22 papers)Prostate Cancer Treatment and Research (19 papers)Epigenetics and DNA Methylation (18 papers)
- Cited by
- Cancer ResearchOncologyImmunology
- Journals
- The EMBO JournalPLoS ONECancer
- Partner nations
- JapanUnited StatesSouth Korea
In The Last Decade
Keiji Shimada
157 papers receiving 4.9k citations
Peers
Comparison fields: 5 of 118
- Molecular Biology 2.5k
- Oncology 1.4k
- Cancer Research 1.0k
- Surgery 876
- Immunology 788
Countries citing papers authored by Keiji Shimada
This map shows the geographic impact of Keiji Shimada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keiji Shimada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keiji Shimada more than expected).
Fields of papers citing papers by Keiji Shimada
This network shows the impact of papers produced by Keiji Shimada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keiji Shimada. The network helps show where Keiji Shimada may publish in the future.
Co-authorship network of co-authors of Keiji Shimada
This figure shows the co-authorship network connecting the top 25 collaborators of Keiji Shimada. A scholar is included among the top collaborators of Keiji Shimada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keiji Shimada. Keiji Shimada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 2 | |
| 3 | 11 | |
| 4 | 0 | |
| 5 | 69 | |
| 6 | 44 | |
| 7 | 133 | |
| 8 | 15 | |
| 9 | 28 | |
| 10 | 61 | |
| 11 | 62 | |
| 12 | 81 | |
| 13 | 28 | |
| 14 | 39 | |
| 15 | 32 | |
| 16 | 36 | |
| 17 | 22 | |
| 18 | 24 | |
| 19 | 58 | |
| 20 | [Surgical strategy for hepatocellular carcinoma of the caudate lobe]. | 10 |
About Keiji Shimada
Keiji Shimada is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 161 papers that have together received 4.9k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (22 papers), Prostate Cancer Treatment and Research (19 papers) and Epigenetics and DNA Methylation (18 papers). The work is most often cited by research in Cancer Research (1.0k citations), Oncology (1.4k citations) and Immunology (788 citations). Keiji Shimada has collaborated with scholars based in Japan, United States and South Korea. Frequent co-authors include Noboru Konishi, Mitsutoshi Nakamura, Eiwa Ishida, Kiyohide Fujimoto, Satoshi Anai, Tomomi Fujii, Kazutake Tsujikawa, Munehiro Kishi, Nobumichi Tanaka and N Konishi. Their work appears in journals such as The EMBO Journal, PLoS ONE and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.